The EPS projection of T2 Biosystems, Inc. (NASDAQ:TTOO) for quarter ended 2016-09-30 is $-0.53. A week before, the EPS forecast was $-0.53 against target of $-0.53, a month earlier. This estimate stood at $-0.53 60 days earlier versus forecast of $-0.53 90 days earlier, confirming a deviation of 0%.
T2 Biosystems, Inc. (NASDAQ:TTOO) reported that 18 days ago, the positive EPS revisions were 1 and negative revisions at 1.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 1, 2, 0 and 1, respectively.
The downgrade of EPS estimates for T2 Biosystems, Inc. (NASDAQ:TTOO) in the preceding 120, 60, 30 and 90 days were 1, 1, 0 and 1, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of T2 Biosystems, Inc. (NASDAQ:TTOO) was $-0.53. This projection was computed after accounting 3 calls. As reported on 2016-05-02 the EPS was $-0.55. The change was $0, demonstrating a percentage deviation of 0%. The projections confirmed a standard deviation of 0.01.
Quarterly Sales Estimates
For the fiscal 2016, the yearly sales target for T2 Biosystems, Inc. (NASDAQ:TTOO) stands at $3.725 and the median estimate at $3.725. Almost 2 analysts announced their estimates.
The highest estimate is $4.45 while the lowest target is $3 showing standard deviation of 1.025%.
As many as 2 analysts released sales estimates reised in upside while 2 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 2 revised sales number projection on upside while 2 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 2 hiked sales estimations and 2 reduced sales forecast. T2 Biosystems, Inc. (NASDAQ:TTOO) stated that the change in forecast was -22.797%.
1 Chart Pattern Every Investor Should Know